The Invisible Rainbow in 9 languages

The political life has its own laws and rules, so has the social life.
The fact that electricity is first of all “an element that is to us more íntimate than the very air that we breathe” (Abbé Nollet 1746) has become a scientific and political means to manipulate the masses without them realizing it because to them the primary function of electricity lies solely in their external world.
Havana syndrome, Sudeck syndrome, neuroses of all kinds, and pandemics ring the bell to the sacred and internal dimension of this mysterious cosmic substance that was known to previous generations.
The Invisible Rainbow recollects its history from the 18th century up to date in a profound way and when reading it one wonders why it is not taught at all levels of the educational system across the planet….
….’The Sole of the Universe’ that produces and sustains Life thro-out all Nature, as well in Animals as in Vegetables” John Wesley the Methodist Church 1760


Cybertorture

So far, the psychiatrists, neurologists and doctors label such reports as schizophrenic, delusional and force people on anti-psychotic medication
https://www.theguardian.com/law/2020/feb/21/un-rapporteur-warns-of-rise-of-cybertorture-to-bypass-physical-ban?fbclid=IwAR0mIvFNEpODW8KspG0XulW8MqkmzSSiO2gskQOgHicfxRjCTgKWV3vjlh0

https://www.ucc.ie/en/media/academic/law/vnuconference2020/26.PTSon_CYBER-TORTURE.docx

https://www.ucc.ie/en/media/academic/law/vnuconference2020/26.PTSon_CYBER-TORTURE.docx

The globalist food chain

I follow the food chain dramas very closely because of the esoteric aspect and impacts of such planetary moves. I will repeat again that the atmosphere contains certain amounts of active substances our science knows nothing about as it has no means yet to detect them. But the plants have the apparatuses that do detect them, absorb them, and thus pass them to us as nourishment not only to the physical bodies but also to the spiritual bodies. Through genetic modifications, even through the majority of drafting, the plants lose this ability and that is one of the aspects of how the spiritual degeneration of humanity proceeds. Quite tragic because totally unnecessary, just the lack of esoteric knowledge and a total misunderstanding of how the Universe operates, on almost every level of our civilization. To grow food on such a major scale in environmentally controlled conditions, that need electricity to operate them, without the “reflection” of the sun’s rays, we will gradually stop fulfilling our cosmic obligations and then we will end as in the Universe 25 experiment. That is why I try to persuade everyone including the major players who invest in such technologies that we need to bring back the CREATOR into the picture. On scientific verifiable bases. Let’s not forget one thing, the globalists are on the same ship as the rest of us. With the right knowledge, we can turn the ship in the right direction. How little faith we have in the LOVE of our CREATOR…..

Federal Register – Notice of Declaration Under the Public Readiness and Emergency Preparedness Act for Countermeasures Against Marburgvirus and/or Marburg Disease

The Secretary is issuing this Declaration pursuant to section 319F-3 of the Public Health Service Act to provide limited immunity for activities related to countermeasures against marburgvirus and/or Marburg disease.

DATES:

The Declaration is effective as of November 25, 2020.

https://www.federalregister.gov/documents/2020/12/09/2020-26972/notice-of-declaration-under-the-public-readiness-and-emergency-preparedness-act-for-countermeasures

Click to access 2020-26972.pdf

SUPPLEMENTARY INFORMATION:

The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of Health and Human Services (the Secretary) to issue a Declaration to provide liability immunity to certain individuals and entities (Covered Persons) against any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of medical countermeasures (Covered Countermeasures), except for claims involving “willful misconduct” as defined in the PREP Act. This Declaration is subject to amendment as circumstances warrant.

The PREP Act was enacted on December 30, 2005, as Public Law 109-148, Division C, Section 2. It amended the Public Health Service (PHS) Act, adding Section 319F-3, which addresses liability immunity, and Section 319F-4, which creates a compensation program. These sections are codified at 42 U.S.C. 247d-6d and 42 U.S.C. 247d-6e, respectively.

The Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), Public Law 113-5, was enacted on March 13, 2013. Among other things, PAHPRA added sections 564A and 564B to the Federal Food, Drug, and Cosmetic (FD&C) Act to provide new authorities for the emergency use of approved products in emergencies and products held for emergency use. PAHPRA accordingly amended the definitions of “Covered Countermeasures” and “qualified pandemic and epidemic products” in Section 319F-3 of the Public Health Service Act (PREP Act provisions), so that products made available under these new FD&C Act authorities could be covered under PREP Act Declarations. PAHPRA also extended the definition of qualified pandemic and epidemic products that may be covered under a PREP Act Declaration to include products or technologies intended to enhance the use or effect of a drug, biological product, or device used against the pandemic or epidemic or against adverse events from these products. The Coronavirus Aid, Relief, and Economic Security (CARES) Act, Public Law 116-136, enacted on March 27, 2020, amended section 319F-3(i)(1)(D) of the PHS Act, to create a new category of covered countermeasures to the PREP Act, namely, respiratory protective devices approved by the National Institute for Occupational Safety and Health (NIOSH) under 42 CFR part 84, or any successor regulations, that the Secretary determines to be a priority for use during a public health emergency declared under section 319 of the PHS Act.

Marburg disease is a severe and often fatal illness in humans caused by marburgviruses, a group of filoviruses of the same family as ebolaviruses. Marburg disease is a highly virulent disease that causes hemorrhagic fever, with a case fatality rate of approximately 88 percent. Humans can become infected with marburgviruses, but it is largely unknown how marburgvirus transmits from its animal host to humans. For previous cases, unprotected contact with infected bat feces or aerosols was deemed the most likely route of infection. After the initial crossover of the virus from host animal to humans, transmission can occur through person-to-person contact. This may happen in several ways: Direct contact to droplets of body fluids from infected persons, or contact with equipment and other objects contaminated with infectious blood or tissues. The virus can spread between humans in close environments and through direct contact. A common route of infection is through nosocomial transmission.

Marburgvirus was first recognized in 1967, when outbreaks of hemorrhagic fever occurred simultaneously in laboratories in Marburg and Frankfurt, Germany and in Belgrade, Yugoslavia (now Serbia). Thirty-one people became ill, initially laboratory workers followed by several medical personnel and family members who had cared for them; seven deaths were reported. The first people infected had been exposed to imported African green monkeys or their tissues while conducting research.

From 1975-2014, there have been 10 reported outbreaks of Marburg disease, and all but one of these outbreaks had an apparent or suspected origin in Africa. These outbreaks have resulted in a total of 435 reported human cases of Marburg disease and 366 deaths among those reported cases; a case fatality rate of approximately of 84%. The recurrent but unpredictable and variable nature of Marburg disease outbreaks and the transmission profile makes marburgviruses a threat to the public health security of the American people, requiring vigilance and a continuing need for development of medical countermeasures. Similar to determinations and experiences with Ebola virus outbreaks, marburgvirus has been determined to have the potential to be a threat to US public health security.

Description of This Declaration by Section

Section I. Determination of Public Health Emergency or Credible Risk of Future Public Health Emergency

Before issuing a Declaration under the PREP Act, the Secretary is required to determine that a disease or other health condition or threat to health constitutes a public health emergency or that there is a credible risk that the disease, condition, or threat may constitute such an emergency.

This determination is separate and apart from the Declaration issued by the Secretary under Section 319 of the PHS Act that a disease or disorder presents a public health emergency or that a public health emergency, including significant outbreaks of infectious diseases or bioterrorist attacks, otherwise exists, or other Declarations or determinations made under other authorities of the Secretary. Accordingly, in Section I of the Declaration, the Secretary determines that marburgviruses and Marburg disease are a credible risk such that Marburg disease or marburgviruses may in the future constitute a public health emergency.

Section II. Factors Considered by the Secretary

In deciding whether and under what circumstances to issue a Declaration with respect to a Covered Countermeasure, the Secretary must consider the desirability of encouraging the design, development, clinical testing or investigation, manufacture, labeling, distribution, formulation, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing, and use of the countermeasure. In Section II of the Declaration, the Secretary states that he has considered these factors.

Section III. Activities Covered by This Declaration Under the PREP Act’s Liability Immunity

The Secretary must delineate the activities for which the PREP Act’s liability immunity is in effect. These activities may include, under conditions as the Secretary may specify, the manufacture, testing, development, distribution, administration, or use of one or more Covered Countermeasures (Recommended Activities). In Section III of the Declaration, the Secretary sets out the activities for which the immunity is in effect.

Section IV. Limited Immunity

The Secretary must also state that liability protections available under the PREP Act are in effect with respect to the Recommended Activities. These liability protections provide that, “[s]ubject to other provisions of [the PREP Act], a covered person shall be immune from suit and liability under federal and state law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or use by an individual of a covered countermeasure if a Declaration has been issued with respect to such countermeasure.” In Section IV of the Declaration, the Secretary states that liability protections are in effect with respect to the Recommended Activities.

Section V. Covered Persons

The PREP Act’s liability immunity applies to “Covered Persons” with respect to administration or use of a Covered Countermeasure. The term “Covered Persons” has a specific meaning and is defined in the PREP Act to include manufacturers, distributors, program planners, and qualified persons, and their officials, agents, and employees, and the United States. The PREP Act further defines the terms “manufacturer,” “distributor,” “program planner,” and “qualified person” as described below.

A manufacturer includes a contractor or subcontractor of a manufacturer; a supplier or licenser of any product, intellectual property, service, research tool or component or other article used in the design, development, clinical testing, investigation or manufacturing of a Covered Countermeasure; and any or all the parents, subsidiaries, affiliates, successors, and assigns of a manufacturer.

A distributor means a person or entity engaged in the distribution of drugs, biologics, or devices, including but not limited to: Manufacturers; re-packers; common carriers; contract carriers; air carriers; own-label distributors; private-label distributors; jobbers; brokers; warehouses and wholesale drug warehouses; independent wholesale drug traders; and retail pharmacies.

A program planner means a state or local government, including an Indian tribe; a person employed by the state or local government; or other person who supervises or administers a program with respect to the administration, dispensing, distribution, provision, or use of a Covered Countermeasure, including a person who establishes requirements, provides policy guidance, or supplies technical or scientific advice or assistance or provides a facility to administer or use a Covered Countermeasure in accordance with the Secretary’s Declaration. Under this definition, a private sector employer or community group or other “person” can be a program planner when it carries out the described activities.

A qualified person means a licensed health professional or other individual authorized to prescribe, administer, or dispense Covered Countermeasures under the law of the state in which the Covered Countermeasure was prescribed, administered, or dispensed; or a person within a category of persons identified as qualified in the Secretary’s Declaration. Under this definition, the Secretary can describe in the Declaration other qualified persons, such as volunteers, who are Covered Persons. Section V describes other qualified persons covered by this Declaration. The PREP Act also defines the word “person” as used in the Act: A person includes an individual, partnership, corporation, association, entity, or public or private corporation, including a federal, state, or local government agency or department.

Section V of the Declaration describes Covered Persons, including Qualified Persons. The Declaration includes all persons and entities defined as Covered Persons under the PREP Act.

Section VI. Covered Countermeasures

As noted above, Section III of the Declaration describes the activities (referred to as “Recommended Activities”) for which liability immunity is in effect. Section VI of the Declaration identifies the Covered Countermeasures for which the Secretary has recommended such activities. The PREP Act states that a “Covered Countermeasure” must be a “qualified pandemic or epidemic product,” or a “security countermeasure,” as described immediately below; a drug, biological product or device authorized for emergency use in accordance with Sections 564, 564A, or 564B of the FD&C Act; or respiratory protective devices approved by the National Institute for Occupational Safety and Health (NIOSH) under 42 CFR part 84, or any successor regulations, that the Secretary determines to be a priority for use during a public health emergency declared under section 319 of the PHS Act.

A qualified pandemic or epidemic product means a drug or device, as defined in the FD&C Act or a biological product, as defined in the PHS Act that is (i) Manufactured, used, designed, developed, modified, licensed or procured to diagnose, mitigate, prevent, treat, or cure a pandemic or epidemic or limit the harm such a pandemic or epidemic might otherwise cause; (ii) manufactured, used, designed, developed, modified, licensed, or procured to diagnose, mitigate, prevent, treat, or cure a serious or life-threatening disease or condition caused by such a drug, biological product, or device; (iii) or a product or technology intended to enhance the use or effect of such a drug, biological product, or device.

A security countermeasure is a drug or device, as defined in the FD&C Act or a biological product, as defined in the PHS Act that (i)(a) The Secretary determines to be a priority to diagnose, mitigate, prevent, or treat harm from any biological, chemical, radiological, or nuclear agent identified as a material threat by the Secretary of Homeland Security, or (b) to diagnose, mitigate, prevent, or treat harm from a condition that may result in adverse health consequences or death and may be caused by administering a drug, biological product, or device against such an agent; and (ii) is determined by the Secretary of Health and Human Services to be a necessary countermeasure to protect public health.

To be a Covered Countermeasure, qualified pandemic or epidemic products or security countermeasures also must be approved or cleared under the FD&C Act; approved by the National Institute for Occupational Safety and Health (NIOSH) under 42 CFR part 84, or any successor regulations, that the Secretary determines to be a priority for use during a public health emergency declared under section 319 of the PHS Act; licensed under the PHS Act; or authorized for emergency use under Sections 564, 564A, or 564B of the FD&C Act.

A qualified pandemic or epidemic product also may be a Covered Countermeasure when it is subject to an exemption (that is, it is permitted to be used under an Investigational Drug Application or an Investigational Device Exemption) under the FD&C Act and is the object of research for possible use for diagnosis, mitigation, prevention, treatment, or cure, or to limit harm of a pandemic or epidemic or serious or life-threatening condition caused by such a drug or device.

A security countermeasure also may be a Covered Countermeasure if it may reasonably be determined to qualify for approval or licensing within 10 years after the Department’s determination that procurement of the countermeasure is appropriate.

Section VI lists countermeasures against marburgvirus and/or Marburg disease that are Covered Countermeasures under this declaration.

Section VI also refers to the statutory definitions of Covered Countermeasures to make clear that these statutory definitions limit the scope of Covered Countermeasures. Specifically, the Declaration notes that Covered Countermeasures must be “qualified pandemic or epidemic products,” or “security countermeasures,” or drugs, biological products, respiratory protective devices, or devices authorized for investigational or emergency use, as those terms are defined in the PREP Act, the FD&C Act, and the Public Health Service Act.

Section VII. Limitations on Distribution

The Secretary may specify that liability immunity is in effect only to Covered Countermeasures obtained through a particular means of distribution. The Declaration states that liability immunity is afforded to Covered Persons for Recommended Activities related to (a) Present or future federal contracts, cooperative agreements, grants, other transactions, interagency agreements, or memoranda of understanding or other federal agreements; or (b) Activities authorized in accordance with the public health and medical response of the Authority Having Jurisdiction to prescribe, administer, deliver, distribute, or dispense the Covered Countermeasures following a Declaration of an emergency.

Section VII defines the terms “Authority Having Jurisdiction” and “Declaration of an emergency.” We have specified in the definition that Authorities having jurisdiction include federal, state, local, and tribal authorities and institutions or organizations acting on behalf of those governmental entities.

For governmental program planners only, liability immunity is afforded only to the extent they obtain Covered Countermeasures through voluntary means, such as (1) donation; (2) commercial sale; (3) deployment of Covered Countermeasures from federal stockpiles; or (4) deployment of donated, purchased, or otherwise voluntarily obtained Covered Countermeasures from state, local, or private stockpiles. This last limitation on distribution is intended to deter program planners that are government entities from seizing privately held stockpiles of Covered Countermeasures. It does not apply to any other Covered Persons, including other program planners who are not government entities.

Section VIII. Category of Disease, Health Condition, or Threat

The Secretary must identify in the Declaration, for each Covered Countermeasure, the categories of diseases, health conditions, or threats to health for which the Secretary recommends the administration or use of the countermeasure. In Section VIII of the Declaration, the Secretary states that the disease threat for which he recommends administration or use of the Covered Countermeasures is Marburg disease caused by marburgviruses or virus mutating therefrom.

Section IX. Administration of Covered Countermeasures

The PREP Act does not explicitly define the term “administration” but does assign the Secretary the responsibility to provide relevant conditions in the Declaration. In Section IX of the Declaration, the Secretary defines “Administration of a Covered Countermeasure,” as follows:

Administration of a Covered Countermeasure means physical provision of the countermeasures to recipients, or activities and decisions directly relating to public and private delivery, distribution, and dispensing of the countermeasures to recipients; management and operation of countermeasure programs; or management and operation of locations for purpose of distributing and dispensing countermeasures.

The definition of “administration” extends only to physical provision of a countermeasure to a recipient, such as vaccination or handing drugs to patients, and to activities related to management and operation of programs and locations for providing countermeasures to recipients, such as decisions and actions involving security and queuing, but only insofar as those activities directly relate to the countermeasure activities. Claims for which Covered Persons are provided immunity under the Act are losses caused by, arising out of, relating to, or resulting from the administration to or use by an individual of a Covered Countermeasure consistent with the terms of a Declaration issued under the Act. Under the definition, these liability claims are precluded if they allege an injury caused by a countermeasure, or if the claims are due to manufacture, delivery, distribution, dispensing, or management and operation of countermeasure programs at distribution and dispensing sites.

Thus, it is the Secretary’s interpretation that, when a Declaration is in effect, the Act precludes, for example, liability claims alleging negligence by a manufacturer in creating a vaccine, or negligence by a health care provider in prescribing the wrong dose, absent willful misconduct. Likewise, the Act precludes a liability claim relating to the management and operation of a countermeasure distribution program or site, such as a slip-and-fall injury or vehicle collision by a recipient receiving a countermeasure at a retail store serving as an administration or dispensing location that alleges, for example, lax security or chaotic crowd control. However, a liability claim alleging an injury occurring at the site that was not directly related to the countermeasure activities is not covered, such as a slip and fall with no direct connection to the countermeasure’s administration or use. In each case, whether immunity is applicable will depend on the particular facts and circumstances.

Section X. Population

The Secretary must identify, for each Covered Countermeasure specified in a Declaration, the population or populations of individuals for which liability immunity is in effect with respect to administration or use of the countermeasure. Section X of the Declaration identifies which individuals should use the countermeasure or to whom the countermeasure should be administered—in short, those who should be vaccinated or take a drug or other countermeasure. Section X provides that the population includes “any individual who uses or who is administered a Covered Countermeasure in accordance with the Declaration.”

It should be noted that under the PREP Act, liability protection extends beyond the Population specified in the Declaration. Specifically, liability immunity is afforded (1) To manufacturers and distributors without regard to whether the countermeasure is used by or administered to this population, and (2) to program planners and qualified persons when the countermeasure is either used by or administered to this population or the program planner or qualified person reasonably could have believed the recipient was in this population. Section X of the Declaration includes these statutory conditions in the Declaration for clarity.

Section XI. Geographic Area

The Secretary must identify, for each Covered Countermeasure specified in the Declaration, the geographic area or areas for which liability immunity is in effect, including, as appropriate, whether the Declaration applies only to individuals physically present in the area or, in addition, applies to individuals who have a described connection to the area. Section XI of the Declaration provides that liability immunity is afforded for the administration or use of a Covered Countermeasure without geographic limitation. This could include claims related to administration or use in countries outside the U.S. It is possible that claims may arise in regard to administration or use of the Covered Countermeasures outside the U.S. that may be resolved under U.S. law.

In addition, the PREP Act specifies that liability immunity is afforded (1) to manufacturers and distributors without regard to whether the countermeasure is used by or administered to individuals in the geographic areas, and (2) to program planners and qualified persons when the countermeasure is either used or administered in the geographic areas or the program planner or qualified person reasonably could have believed the countermeasure was used or administered in the areas. Section XI of the Declaration includes these statutory conditions in the Declaration for clarity.

Section XII. Effective Time Period

The Secretary must identify, for each Covered Countermeasure, the period or periods during which liability immunity is in effect, designated by dates, milestones, or other description of events, including factors specified in the PREP Act. Section XII of the Declaration extends the effective period for different means of distribution of Covered Countermeasures through August 1, 2025.

Section XIII. Additional Time Period of Coverage

The Secretary must specify a date after the ending date of the effective time period of the Declaration that is reasonable for manufacturers to arrange for disposition of the Covered Countermeasure, including accepting returns of Covered Countermeasures, and for other Covered Persons to take appropriate actions to limit administration or use of the Covered Countermeasure. In addition, the PREP Act specifies that, for Covered Countermeasures that are subject to a Declaration at the time they are obtained for the Strategic National Stockpile (SNS) under 42 U.S.C. 247d-6b(a), the effective period of the Declaration extends through the time the countermeasure is used or administered. Liability immunity under the provisions of the PREP Act and the conditions of the Declaration continue during these additional time periods. Thus, liability immunity is afforded during the “Effective Time Period,” described under Section XII of the Declaration, plus the “Additional Time Period” described under Section XIII of the Declaration.

Section XIII of the Declaration provides for 12 months as the Additional Time Period of coverage after expiration of the Declaration. Section XIII also explains the extended coverage that applies to any product obtained for the SNS during the effective period of the Declaration.

Section XIV. Countermeasures Injury Compensation Program

Section 319F-4 of the PHS Act, 42 U.S.C. 247d-6e, authorizes the Countermeasures Injury Compensation Program (CICP) to provide benefits to eligible individuals who sustain a serious physical injury or die as a direct result of the administration or use of a Covered Countermeasure. Compensation under the CICP for an injury directly caused by a Covered Countermeasure is based on the requirements set forth in this Declaration, the administrative rules for the Program, and the statute. To show direct causation between a Covered Countermeasure and a serious physical injury, the statute requires “compelling, reliable, valid, medical and scientific evidence.” The administrative rules for the Program further explain the necessary requirements for eligibility under the CICP. Please note that, by statute, requirements for compensation under the CICP may not align with the requirements for liability immunity provided under the PREP Act. Section XIV of the Declaration, “Countermeasures Injury Compensation Program,” explains the types of injury and standard of evidence needed to be considered for compensation under the CICP.

Further, the administrative rules for the CICP specify that if countermeasures are administered or used outside the United States, only otherwise eligible individuals at United States embassies, military installations abroad (such as military bases, ships, and camps) or at North Atlantic Treaty Organization (NATO) installations (subject to the NATO Status of Forces Agreement) where American servicemen and servicewomen are stationed may be considered for CICP benefits. Other individuals outside the United States may not be eligible for CICP benefits.

Section XV. Amendments

Section XV of the Declaration confirms that the Secretary may amend any portion of this Declaration through publication in the Federal Register.

Declaration

Declaration for Public Readiness and Emergency Preparedness Act Coverage for Countermeasures Against Marburgvirus and/or Marburg Disease

I. Determination of Public Health Emergency

42 U.S.C. 247d-6d(b)(1)

I have determined that Marburg disease and marburgviruses are a credible risk such that Marburg disease or marburgviruses may in the future constitute a public health emergency. This Declaration must be construed in accordance with the Advisory Opinions of the Office of the General Counsel (Advisory Opinions). I incorporate those Advisory Opinions as part of this Declaration.[1] This Declaration is a “requirement” under the PREP Act.

II. Factors Considered

42 U.S.C. 247d-6d(b)(6)

I have considered the desirability of encouraging the design, development, clinical testing, or investigation, manufacture, labeling, distribution, formulation, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing, and use of the Covered Countermeasures.

III. Recommended Activities

42 U.S.C. 247d-6d(b)(1)

I recommend, under the conditions stated in this Declaration, the manufacture, testing, development, distribution, administration, and use of the Covered Countermeasures.

IV. Liability Immunity

42 U.S.C. 247d-6d(a), 247d-6d(b)(1)

Liability immunity as prescribed in the PREP Act and conditions stated in this Declaration is in effect for the Recommended Activities described in Section III.

V. Covered Persons

42 U.S.C. 247d-6d(i)(2), (3), (4), (6), (8)(A) and (B)

Covered Persons who are afforded liability immunity under this Declaration are “manufacturers,” “distributors,” “program planners,” “qualified persons,” and their officials, agents, and employees, as those terms are defined in the PREP Act, and the United States. In addition, I have determined that the following additional persons are qualified persons: (a) Any person authorized in accordance with the public health and medical emergency response of the Authority Having Jurisdiction, as described in Section VII below, to prescribe, administer, deliver, distribute or dispense the Covered Countermeasures, and their officials, agents, employees, contractors and volunteers, following a Declaration of an emergency; (b) any person authorized to prescribe, administer, or dispense the Covered Countermeasures or who is otherwise authorized to perform an activity under an Emergency Use Authorization in accordance with Section 564 of the FD&C Act; and (c) any person authorized to prescribe, administer, or dispense Covered Countermeasures in accordance with Section 564A of the FD&C Act.

VI. Covered Countermeasures

42 U.S.C. 247d-6b(c)(1)(B), 42 U.S.C. 247d-6d(i)(1) and (7)

Covered Countermeasures are any antiviral, any other drug, any biologic, any diagnostic, any other device, or any vaccine, used to treat, diagnose, cure, prevent, or mitigate Marburg disease, or the transmission of marburgviruses or a virus mutating therefrom, or any device used in the administration of any such product, and all components and constituent materials of any such product, or countermeasures for adverse effects of these countermeasures, and countermeasures that otherwise limit the harm caused by the health threat.

Covered Countermeasures must be “qualified pandemic or epidemic products,” or “security countermeasures,” or drugs, biological products, respiratory protective devices or devices authorized for investigational or emergency use, as those terms are defined in the PREP Act, the FD&C Act, and the Public Health Service Act.

VII. Limitations on Distribution

42 U.S.C. 247d-6d(a)(5) and (b)(2)(E)

I have determined that liability immunity is afforded to Covered Persons only for Recommended Activities involving Covered Countermeasures that are related to:

(a) Present or future federal contracts, cooperative agreements, grants, other transactions, interagency agreements, memoranda of understanding, or other federal agreements; or

(b) Activities authorized in accordance with the public health and medical response of the Authority Having Jurisdiction to prescribe, administer, deliver, distribute or dispense the Covered Countermeasures following a Declaration of an emergency.

As used in this Declaration, the terms Authority Having Jurisdiction and Declaration of Emergency have the following meanings:

i. The Authority Having Jurisdiction means the public agency or its delegate that has legal responsibility and authority for responding to an incident, based on political or geographical (e.g., city, county, tribal, state, or federal boundary lines) or functional (e.g., law enforcement, public health) range or sphere of authority.

ii. A Declaration of Emergency means any Declaration by any authorized local, regional, state, or federal official of an emergency specific to events that indicate an immediate need to administer and use the Covered Countermeasures, with the exception of a federal Declaration in support of an Emergency Use Authorization under Section 564 of the FD&C Act unless such Declaration specifies otherwise;

I have also determined that, for governmental program planners only, liability immunity is afforded only to the extent such program planners obtain Covered Countermeasures through voluntary means, such as (1) donation; (2) commercial sale; (3) deployment of Covered Countermeasures from federal stockpiles; or (4) deployment of donated, purchased, or otherwise voluntarily obtained Covered Countermeasures from state, local, or private stockpiles.

VIII. Category of Disease, Health Condition, or Threat

42 U.S.C. 247d-6d(b)(2)(A)

The category of disease, health condition, or threat for which I recommend the administration or use of the Covered Countermeasures is Marburg disease caused by marburgviruses or virus mutating therefrom.

IX. Administration of Covered Countermeasures

42 U.S.C. 247d-6d(a)(2)(B)

Administration of the Covered Countermeasure means physical provision of the countermeasures to recipients, or activities and decisions directly relating to public and private delivery, distribution and dispensing of the countermeasures to recipients, management and operation of countermeasure programs, or management and operation of locations for purpose of distributing and dispensing countermeasures.

X. Population

42 U.S.C. 247d-6d(a)(4), 247d-6d(b)(2)(C)

The populations of individuals include any individual who uses or is administered the Covered Countermeasures in accordance with this Declaration.

Liability immunity is afforded to manufacturers and distributors without regard to whether the countermeasure is used by or administered to this population; liability immunity is afforded to program planners and qualified persons when the countermeasure is used by or administered to this population, or the program planner or qualified person reasonably could have believed the recipient was in this population.

XI. Geographic Area

42 U.S.C. 247d-6d(a)(4), 247d-6d(b)(2)(D)

Liability immunity is afforded for the administration or use of a Covered Countermeasure without geographic limitation.

Liability immunity is afforded to manufacturers and distributors without regard to whether the countermeasure is used by or administered in any designated geographic area; liability immunity is afforded to program planners and qualified persons when the countermeasure is used by or administered in any designated geographic area, or the program planner or qualified person reasonably could have believed the recipient was in that geographic area.

XII. Effective Time Period

42 U.S.C. 247d-6d(b)(2)(B)

Liability immunity for Covered Countermeasures through means of distribution, as identified in Section VII(a) of this Declaration, other than in accordance with the public health and medical response of the Authority Having Jurisdiction and extends through August 1, 2025.

Liability immunity for Covered Countermeasures administered and used in accordance with the public health and medical response of the Authority Having Jurisdiction begins with a Declaration and lasts through (1) the final day the emergency Declaration is in effect, or (2) August 1, 2025, whichever occurs first.

XIII. Additional Time Period of Coverage

42 U.S.C. 247d-6d(b)(3)(B) and (C)

I have determined that an additional 12 months of liability protection is reasonable to allow for the manufacturer(s) to arrange for disposition of the Covered Countermeasure, including return of the Covered Countermeasures to the manufacturer, and for Covered Persons to take such other actions as are appropriate to limit the administration or use of the Covered Countermeasures.

Covered Countermeasures obtained for the SNS during the effective period of this Declaration are covered through the date of administration or use pursuant to a distribution or release from the SNS.

XIV. Countermeasures Injury Compensation Program

42 U.S.C. 247d-6e

The PREP Act authorizes the Countermeasures Injury Compensation Program (CICP) to provide benefits to certain individuals or estates of individuals who sustain a covered serious physical injury as the direct result of the administration or use of the Covered Countermeasures, and benefits to certain survivors of individuals who die as a direct result of the administration or use of the Covered Countermeasures. The causal connection between the countermeasure and the serious physical injury must be supported by compelling, reliable, valid, medical and scientific evidence in order for the individual to be considered for compensation. The CICP is administered by the Health Resources and Services Administration, within the Department of Health and Human Services. Information about the CICP is available at the toll-free number 1-855-266-2427 or http://www.hrsa.gov/​cicp/​.

XV. Amendments

42 U.S.C. 247d-6d(b)(4)

Amendments to this Declaration will be published in the Federal Register, as warranted.

Authority: 42 U.S.C. 247d-6d

Dated: December 2, 2020.

Alex M. Azar II,

Secretary, Department of Health and Human Services.

Footnotes

1.  See, e.g., Advisory Opinion on the Public Readiness and Emergency Preparedness Act and the March 10, 2020 Declaration under the Act, Apr. 17, 2020, as Modified on May 19, 2020, available at https://www.hhs.gov/​guidance/​sites/​default/​files/​hhs-guidance-documents/​prep-act-advisory-opinion-hhs-ogc.pdf (last visited Nov. 24, 2020); Advisory Opinion 20-02 on the Public Readiness and Emergency Preparedness Act and the Secretary’s Declaration under the Act, May 19, 2020, available at https://www.hhs.gov/​guidance/​sites/​default/​files/​hhs-guidance-documents/​advisory-opinion-20-02-hhs-ogc-prep-act.pdf (last visited Nov. 24, 2020); Advisory Opinion 20-03 on the Public Readiness and Emergency Preparedness Act and the Secretary’s Declaration under the Act, Oct. 22, 2020, as Modified on Oct. 23, 2020, available at https://www.hhs.gov/​guidance/​sites/​default/​files/​hhs-guidance-documents/​AO3.1.2_​Updated_​FINAL_​SIGNED_​10.23.20.pdf (last visited Nov. 24, 2020); Advisory Opinion 20-04 on the Public Readiness and Emergency Preparedness Act and the Secretary’s Declaration under the Act, Oct. 22, 2020, as Modified on Oct. 23, 2020, available at https://www.hhs.gov/​guidance/​sites/​default/​files/​hhs-guidance-documents/​AO%204.2_​Updated_​FINAL_​SIGNED_​10.23.20.pdf (last visited Nov. 24, 2020). This is not to suggest that other PREP Act declarations should be construed in a manner contrary to the interpretation provided in the Advisory Opinions. Back to Citation

[FR Doc. 2020-26972 Filed 12-8-20; 8:45 am]

BILLING CODE 4150-37-P

The European Journal of International Law on The far-reaching US proposals to amend the International Health Regulations at the upcoming 75th World Health Assembly: A call for attention

https://www.ejiltalk.org/the-far-reaching-us-proposals-to-amend-the-international-health-regulations-at-the-upcoming-75th-world-health-assembly-a-call-for-attention/

Global health talks clouded by conspiracy theories about pandemic treaty

https://www.washingtonpost.com/world/2022/05/22/wha-who-pandemic-treaty/

and the conspiracy theories from the European Journal of International Law say:

https://www.ejiltalk.org/the-far-reaching-us-proposals-to-amend-the-international-health-regulations-at-the-upcoming-75th-world-health-assembly-a-call-for-attention/

“The World Health Organization is due to Attempt a Power Grab” – This May 22-28, 2022 in Geneva, Switzerland, “a sophisticated diversion to confuse people and get them to ignore the AMENDMENTS to the INTERNATIONAL HEALTH REGULATIONS” (emphasis added)

https://cdn.substack.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F7f3721a2-620e-44ad-9c70-5e97cbb2d1f8_617x969.jpeg
“The Pandemic treaty does not yet exist yet. It is being drafted and negotiated right now. Discussions regarding the Pandemic treaty are important but they are also part of a sophisticated diversion to confuse people and get them to ignore the immediate concern which is the Amendments to the IHR being considered by the World Health Assembly this May 22-28.
They are very likely to pass” unless the are strong protests of the public from all countries concerned.

Sudeck’s disease stage 1, or diabetic Charcot’sfoot stage 0? Case report and assessment of the diagnostic value of MRI

How many people have been affected by this diagnosis? In the US 200 000 people a year if not more and a similar situation can be found elsewhere in the world. More research is advisable to find out what percentage of these diagnoses are caused by the electromagnetic or ultrasonic fields, a variation of the Havana syndrome. How much suffering do people have to go through this debilitating condition and what cost does it represent to the health insurance industry?
Do we actually understand that we are legally committing crimes against humanity under the “Heaven’s Eye”?

There has been done the extensive research in this field, for example:
https://zoryglaser.com/zory-archives-date/

From Zory’s Archive – Dr. Magda Havas, PhD.

This picture shows the condition caused by the external radiation

Tom Bearden On Human Mind Control Experimentation

So who and when is finally going to illegalize one of the very sources of unimaginable hatred within the atmosphere that I witnessed? We are talking about reality, not sci-fi. If we do not do it, the Creator will

Tom Bearden On Human
Mind Control Experimentation
From Eleanor White eleanor@raven1.net From A. Tyner atyner@nimbus.ocis.temple.edu 6-19-1

Bearden, Tom, “Mind Control and EM Wave Polarization Transductions – Part I, II & III”   I typed this excerpt because it does not print out on one page. Originally published in Explore (Vol. 9, No. 4) 1999, page 8 of Part III of the article posted at: http://www.cheniere.org/explore%20articles/mind%20control3/p08.jpg     Potential U.S. Rogue Groups and Two Recent Examples   Meanwhile, rogue groups amongst Western clandestine mind control researchers will probably arise if they have not already done so. They will likely seek to increase their personal control and further isolate the programs from orthodox government review and from government and legislative control. They may even divert the research into highly illegal and unethical means, because it furthers their own rogue agendas. That is how clandestine U.S. government research can sometimes go sour, unless great care is exercised by the oversight committees in the House and the Senate.   Sometimes when rogue groups do gain control and total secrecy of a given new technological area, then what appears to be “U.S. government operations” do start to encompass a criminal and unethical operations (sic), hidden usually beneath the deep veil of high classification. Also, if it’s “scientific,” no one is ever brought to justice, even if the “evil science actions” are uncovered and publicly revealed.   We Certainly Have Proof of Such Rogue Activity. For Example, Here are Two Prominent Cases   1. For three decades, scientists from the U.S. government, universities, and civilian contractors secretly conspired to treat unsuspecting human patients with whole body nuclear radiation, including some retarded children and cancer patients. Some of those patients _ including some of the retarded children _ died as a result. These illegal experiments were conducted in great secrecy, and the results were highly classified. Eventually these actions were revealed, and a Presidential investigation committee investigated. These experiments would seem to be little different from the WWII Nazi and Japanese experiments on human prisoners. Are those U.S. scientists who were responsible for those retarded children’s deaths any different from the Nazi scientists and criminals we executed at Nuremberg? So what happened when this terrible thing finally came out into the open? President Clinton publicly apologized! How many of the responsible scientists were indicted for murder? Not one. None is every going to be.   Suppose a doctor here in South Alabama with his own private clinic had secretly irradiated those human patients and retarded children with whole body nuclear radiation, over a period of 30 years, resulting in some agonizing deaths. How many state and federal agencies would have come after him with arrest warrants? Probably about 50 or so. Would he have been indicted, tried, convicted, and executed or sent to prison for life? Absolutely! Would the President of the United States have apologized? Not on your life; he would have turned it over to the U.S. Attorney General with a strong directive to investigate and prosecute on criminal charges.   2. Again for three decades, scientists from (i) the U.S. Government, (ii) universities, and (iii) civilian contractors conspired to give poor syphilitic blacks in Tuskegee, Alabama a placebo while ostensibly treating them for syphilis. The purpose of the program was to deliberately observe and record the ravages of the disease to its fruition in their wracked bodies. So the scientists deliberately sat there and watched their brains rot and their bodies rot. They kept meticulous notes, of course. It was very scientific and it was macabre. They “treated” some 400 Blacks in the “program.” Over 100 blacks died as a result of those ghoulish experiments. So what happened when this gruesome thing was revealed? Again President Clinton publicly apologized. The head of the executive branch did not turn the macabre matter over to his Attorney General to prosecute. How many of these scientists were indicted? Not one. How many are going to be indicted? Not one. Suppose again this had been done by a private doctor in his own private clinic. You get the point.   There is No Punishment for Rogue Scientific Groups   Shockingly, the U.S. government at the highest level has shown (and these are not all such cases by any means!) that mass crimes against U.S. civilians, perpetrated by portions of the U.S. scientific community in direct conspiracy and in secret, will likely be condoned. The perpetrators will not be indicted, tried, or convicted. (emphasis in the original)   Note the connection of the “rogue groups” thesis to the above incidents. Note how rogue scientific groups got away with it in both these cases. There may be other rogue scientific groups getting away with such things today. They should not be able to get away with it. But they can.   Perhaps a most startling additional part of those two incidents is that there was no great public outcry from scientific community, deploring these murders and demanding that the criminal scientists be indicted and tried.   As the old saying goes, “By their silence they have convicted themselves.” The organized scientific community, as a community, has shown that it has little or no ethics, and _ while deploring any scientific murdering that “gets revealed,” _ is not really interested in justice. In short, much of the U.S. scientific community may now have very little ethics left. (emphasis in original)   We are not talking about normal individual science, but the Big Science community. There is a whale of a difference between the two. In the Big Science community, there can be and there are rogue groups. Lots of them. There is deep cover, deep classification. And there is very probably advanced mind control research and testing, be it legal or illegal. Hopefully, most of it is legal and constrained. However, some of it is almost certain to be illegal and ill constrained.   Human beings are still human beings. All the good and evil is still there, regardless of the group. The stage settings change, but the cast of characters and the play never change.   It’s sad, but ’twas ever thus. Hidden parts of our own governments _ and other governments throughout the world _ are no different from the old medieval groups, where nobles etc. were always plotting against the king, or using the king’s power for their own nefarious end. The rogue groups today are no different from all the scheming and conniving groups that destroyed the Roman Empire. Great empires fall from within, not usually from without! (emphasis in original)   Conclusion   …Let us hope this great new area, already off to a bad start, can be bridled and steered in the direction of helping and healing people, instead of killing or abusing them. The excesses in its bad use is a potent threat to all nations on Earth. Yet it can revolutionize medical science, education, communication, and psychology. Eventually it can engineer the mind and memory directly, beneficially…

MainPage
http://www.rense.com

Moderna Asks F.d.a. to Authorize its Vaccine for Children Under 6

https://www.cnbc.com/2022/04/28/moderna-asks-fda-to-authorize-covid-vaccine-for-kids-under-6-years-old.html

https://abcnews.go.com/Health/wireStory/moderna-seeks-1st-covid-shots-littlest-kids-84366263

The most psychopathic and megalomaniac governance of this planet in the history of all civilizations and the most brainwashed masses who do not even realize that.
Utterly depressing and I dare to say criminal to expose the CREATOR’s children to the plastic bag’s dictates and depart to the remote private islands. What a disgraceful deviation from The Ray of Creation!
Where are the conscious leaders? Do not tell me that this has been the wish of our MOST MOST HOLY SUN ABSOLUTE. Then I would know you are the fallen angels.

Time as an enemy and a friend

https://wikileaks.org/COP-26.html

Dagmar Palmerova
….
Czech Republic
15.10.2021

The Honorable Merrick GarlandAssociate Attorney General 
U.S. Department of Justice
950 Pennsylvania Avenue, NW
Washington, DC 20530-0001

Dear Mr. Attorney General,

There are millions of people across the world waiting 11 years for the United States Department of Justice to reconsider its position on Mr. Julian Assange’s case. Everything has been said and written so many times that only the thunderous power of utter silence would surpass that.

When zooming out of opinions and generalizations of pros and against, of powers versus human rights, we can see the classical play of polarized forces of good and evil.

By studying the domain of esoterics anyone can see that superpowers have acquired their dominations over the masses through the classified development of the publicly accessible esoteric science, which has always been far ahead of the orthodox stream.

The impact of the application of such science surpasses the sovereign territories of all countries and it can destroy the whole planet, so far legally, because there are no laws that would protect us against it. The general public does not know about such science, not even the medical industry. From such a point of view, the use of espionage laws of the Dark Ages in the 21st century, where the whole planet shares information in a split of a second simply does not correspond with the enlarged visions of the majority of contemporary humans.

We need to be informed and trained to deal with the new horizons of life on our planet as an inseparable part of the entire Universe. „Safe and effective“ level of communication from such an angle of view is very unsafe and ineffective in the long run.

I am not a judge, rather a subject to be judged and not only in the case of Mr. Julian Assange and Wikileaks,

But to take free information from the public domain, experiment with it freely and secretly in the public domain, make the results states’ secrets, and jail the persons that bring it back to the public domain is called subjective justice.

Apart from this subjective, geographical role justice has also the objective role, superior to the first, to ensure that human conduct is in accordance with the objective laws of the Universe, encoded in the original plan for the GOOD of the whole CREATION. To reconcile both is a difficult and responsible role, for which I wish you all help of the MOST HOLY ABSOLUTE.

Respectfully yours,

Dagmar Palmerova

One copy sent to the US Embassy in Prague and to the Czech foreign minister

Dr. Zory Glaser RF/Microwave research archives

WordPress will not connect me to this site so the link needs to be copied and pasted to the readers’ internet device
https://zoryglaser.com/zory-archives-date/

Dr. Zory Glaser has donated his RF/Microwave research archives to Professor Magda Havas of Trent University.

We thank Dr. Glaser for so generously sharing his body work on the effects of electromagnetic and radio frequency radiation.

Condition and legibility of original documents means the quality of the OCR-scanned PDF files found here varies.

Documents Expose US Biological Experiments in Ukraine and Georgia

https://armswatch.com/documents-expose-us-biological-experiments-on-allied-soldiers-in-ukraine-and-georgia/
https://armswatch.com/the-pentagon- bio-weapons/
The question arises- why do the governments prohibit so many functions in response to the artificially created pandemics yet do permit or even order the engineering of deadly viruses that cause pandemics?

Attorney presents evidence to Congress that COVID-19 vaccines are one of the greatest frauds in history

Attorney Thomas Renz, who publicized data from the Department of Defense showing a significant rise in serious illness and injury in military personnel following the rollout of COVID-19 vaccines in 2021, has issued a special legal notice with nearly 200 pages of supporting evidence. Some of the m

Source: Attorney presents evidence to Congress that COVID-19 vaccines are one of the greatest frauds in history

Electromagnetic weapons

The word “nuclear” has been used as a means to create fear in the public. In times when the truth cannot be stated directly one has to look at everything as if it were a symbol for something else, perhaps the truth? Or to mislead him/her even further from the truth?
The military experts say that the next war never uses the same order of weaponry. So if nuclear weaponry were already used 70 years ago, it would not be the leading means in the next one. Besides, why would you use the nuclear means that destroy not just the chosen targets but the whole territories for centuries to come, when you have the invisible, remotely controlled directed energy technology of psychotronic nature that destroys only what you want? It has been kept officially in darkness, despite generating billions of dollars on the world’s market stage. It is invisible, electronically controllable, and able to either just manipulate or completely incapacitate, even evaporate any object it chooses. Its source can be land-based, using cell towers, wi-fi technologies, satellites, etc. An ordinary person cannot hide from it anywhere on earth. They have been passed down to the private sector and Gladio armies’ style public and we use them indirectly via smartphones in so far legal, sadistic show-business that generates substantial wealth to many globally based companies and their customers.
In 2001 State Duma adopted Article 6 of the Federal Law of Russia on weapons by forbidding to circulate civil and service weapons and other items, “that have a damaging effect based on the use of electromagnetic, light, thermal, infrasound radiation….”
How we want but mainly can deal with it is a real puzzle to me. Maybe we do not? Perhaps that would be that hidden meaning of the word “nuclear”?